新規登録 | ログイン | FAQ      [?] 

タグ: pd [286 articles]

Recent papers classified by the tag pd.
  • Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure
    European Journal of Clinical Investigation, Vol. 38, No. 5. (May 2008), pp. 296-305.
    posted to pd kidney gdp age by yavanna on 2008-05-07 15:18:38 as **
  • Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies
    Journal of the National Cancer Institute, Vol. 98, No. 9. (3 May 2006), pp. 580-598.
    by Paul Workman, Eric O Aboagye, Yuen-Li Chung, John R Griffiths, Rachel Hart, Martin O Leach, Ross J Maxwell, Paul M Mcsheehy, Pat M Price, Jamal Zweit, For
    posted to clinical-trial drug-development imaging mri pd pet pk review by xtizon on 2008-03-12 10:24:24 as *****
  • notes The interactive thread: exploring methods for multi-disciplinary design
    (2004), pp. 103-112.
    by Wendy E Mackay
  • On the move with a magic thing: role playing in concept design of mobile services and devices
    (2000), pp. 193-202.
    by Giulio Iacucci, Kari Kuutti, Mervi Ranta
  • Differences in sleep in patients with parkinson's disease
    Electroencephalography and Clinical Neurophysiology, Vol. 38, No. 6. (June 1975), pp. 653-657.
    by J Mouret
    posted to and pd sleep by wada1 on 2005-03-22 09:55:09 as read
  • A review of normal sleep and its disturbances in Parkinson's disease
    Parkinsonism & Related Disorders, Vol. 5, No. 1-2. (April 1999), pp. 1-17.
    by P Pal, S Calne, Ali Samii, J Fleming
    posted to and pd sleep by wada1 on 2005-03-22 09:54:35 as read
  • Parkinson's disease and sleep
    Sleep Medicine Reviews, Vol. 7, No. 2. (April 2003), pp. 115-129.
    by Diego Garcia-Borreguero, Oscar Larrosa, Mauricio Bravo
    posted to and pd sleep by wada1 on 2005-03-22 09:53:52 as read
  • Sleep and fatigue in Parkinson's disease
    Parkinsonism & Related Disorders, Vol. 10, No. Supplement 1. (May 2004), pp. S27-S35.
    by Joseph H Friedman, Kelvin L Chou
    posted to and pd sleep by wada1 on 2005-03-22 09:50:58 as read
  • The Crossed Response Inhibition Task in Parkinson's Disease: Disinhibition Hyperkinesia
    Neurocase, Vol. 13, No. 3. (June 2007), pp. 158-164.
    posted to response_inhibition pd frontal-executive cri-task by susannah on 2008-05-18 01:54:49 as **
  • Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo
    Nature, Vol. 448, No. 7149., pp. 73-77.
    by Päivi Lindholm, Merja H Voutilainen, Juha Laurén, Johan Peränen, Veli-Matti Leppänen, Jaan-Olle Andressoo, Maria Lindahl, Sanna Janhunen, Nisse Kalkkinen, Tõnis Timmusk, Raimo K Tuominen, Mart Saarma
  • Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors.
    Neurosci Lett, Vol. 421, No. 3. (29 June 2007), pp. 239-244.
    by YY Tian, CJ Tang, JN Wang, Y Feng, XW Chen, L Wang, X Qiao, SG Sun
    posted to gdnf pd vegf by stevezhang on 2007-07-26 21:51:52 as ** along with 1 group SGMO_ZFP
  • Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
    Gene Ther, Vol. 9, No. 6. (March 2002), pp. 381-389.
    posted to aav gdnf pd by stevezhang on 2006-06-18 08:06:06 as ** along with 1 group SGMO_ZFP
  • Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
    Exp Neurol, Vol. 206, No. 2. (August 2007), pp. 308-317.
    posted to pd pedf by stevezhang on 2008-02-08 19:03:26 as **
  • Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
    Exp Neurol, Vol. 160, No. 1. (November 1999), pp. 205-214.
    by RJ Mandel, RO Snyder, SE Leff
    posted to aav gdnf pd by stevezhang on 2006-08-26 02:18:46 as ** along with 1 group SGMO_ZFP
  • Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
    Mov Disord, Vol. 22, No. 8. (18 April 2007), pp. 1124-1132.
    by Christopher D D Herzog, Biplob Dass, James E E Holden, James Stansell, Mehdi Gasmi, Mark H H Tuszynski, Raymond T T Bartus, Jeffrey H H Kordower
    posted to aav ceregene gdnf monkey ntn pd by stevezhang on 2007-07-23 22:20:04 as ** along with 1 group SGMO_ZFP
  • Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys.
    Ann Neurol, Vol. 60, No. 6. (December 2006), pp. 706-715.
    by JH Kordower, CD Herzog, B Dass, RA Bakay, J Stansell, M Gasmi, RT Bartus
    posted to aav gdnf monkey ntn pd by stevezhang on 2007-07-23 22:18:22 as ** along with 1 group SGMO_ZFP
  • AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson's disease.
    Neurobiol Dis, Vol. 27, No. 1. (July 2007), pp. 67-76.
    by M Gasmi, EP Brandon, CD Herzog, A Wilson, KM Bishop, EK Hofer, JJ Cunningham, MA Printz, JH Kordower, RT Bartus
    posted to aav gdnf ntn pd by stevezhang on 2007-07-23 22:17:09 as ** along with 1 group SGMO_ZFP
  • Striatal Delivery of Neurturin by CERE-120, an AAV2 Vector for the Treatment of Dopaminergic Neuron Degeneration in Parkinson's Disease.
    Mol Ther, Vol. 15, No. 1. (January 2007), pp. 62-68.
    by M Gasmi, CD Herzog, EP Brandon, JJ Cunningham, GA Ramirez, ET Ketchum, RT Bartus
    posted to aav gdnf ntn pd by stevezhang on 2007-07-23 22:16:24 as ** along with 1 group SGMO_ZFP
  • Socio-technical environments supporting people with cognitive disabilities using public transportation
    ACM Trans. Comput.-Hum. Interact., Vol. 12, No. 2. (June 2005), pp. 233-262.
    by Stefan Carmien, Melissa Dawe, Gerhard Fischer, Andrew Gorman, Anja Kintsch, James
  • Learning and collaboration across generations in a community
    (2003), pp. 205-225.
    by Mary B Rosson, John M Carroll
    posted to cscwproject design pd by shaun on 2006-06-13 11:36:14 as **
  • Participatory Design: Principles and Practices
    (1993)
    by Douglas Schuler, Aki Namioka
    edited by Douglas Schuler, Aki Namioka
    posted to hci pd reading-list by sga72 on 2007-09-11 23:00:22 as ***** along with 2 people and 1 group maike rlai MITCCI
  • Design at Work: Cooperative Design of Computer Systems
    (01 April 1991)
    by Joan Greenbaum
    posted to hci pd reading-list by sga72 on 2007-09-11 22:59:29 as read along with 3 people sabunome maike aku8000
  • Participatory Design: Issues and Concerns
    Comput. Supported Coop. Work, Vol. 7, No. 3-4. (1998), pp. 167-185.
    by Finn Kensing, Jeanette Blomberg
  • Ways of grounding imagination
    (2004), pp. 193-203.
    by Monika Bűscher, Mette A Eriksen, Jannie F Kristensen, Preben H Mogensen
    posted to hdm-acid-net-au innovation pd by rcooper on 2006-02-07 01:39:49 as **** along with 3 people noahwf maike argo
  • Participatory design
    Communications of the ACM, Vol. 36, No. 6. (June 1993), pp. 24-28.
    by Michael J Muller, Sarah Kuhn
  • An update on functional neuroimaging of parkinsonism and dystonia.
    Curr Opin Neurol, Vol. 19, No. 4. (August 2006), pp. 412-419.
    posted to dystonia pd pet by ntvandehey on 2007-08-02 22:48:50 as **
  • Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.
    J Neurol Neurosurg Psychiatry, Vol. 73, No. 5. (November 2002), pp. 517-523.
    by M Ghaemi, R Hilker, J Rudolf, J Sobesky, WD Heiss
    posted to dopamine fdg f-dopa mri msa pd pet raclopride by ntvandehey on 2007-08-02 22:30:27 as ***
  • Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation
    J Neurol Neurosurg Psychiatry, Vol. 76, No. 9. (1 September 2005), pp. 1217-1221.
    by R Hilker, AT Portman, J Voges, MJ Staal, L Burghaus, T van Laar, A Koulousakis, RP Maguire, J Pruim, BM de Jong, K Herholz, V Sturm, W-D Heiss, KL Leenders
    posted to dbs f-dopa pd stn by ntvandehey on 2007-08-03 14:41:36 as **
  • Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD
    Neurology, Vol. 61, No. 6. (23 September 2003), pp. 816-821.
    posted to dbs pd rcbf stn by ntvandehey on 2007-08-03 14:34:41 as ** along with 1 person mbolding
  • In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.
    J Cereb Blood Flow Metab, Vol. 27, No. 7. (July 2007), pp. 1407-1415.
    by V Sossi, JE Holden, GJ Topping, ML Camborde, RA Kornelsen, SE McCormick, J Greene, AR Studenov, TJ Ruth, DJ Doudet
  • Cellular principles underlying normal and pathological activity in the subthalamic nucleus
    Current Opinion in Neurobiology, Vol. 16, No. 6. (December 2006), pp. 621-628.
    by Mark D Bevan, Jeremy F Atherton, Jerome Baufreton
    posted to dbs extra-striatal pd stn by ntvandehey on 2007-09-21 20:42:25 as ** along with 1 person mbolding
  • Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
    Lancet Neurol, Vol. 3, No. 5. (May 2004), pp. 309-316.
    by AE Lang, JA Obeso
    posted to dopamine f-dopa pd treatment by ntvandehey on 2007-09-21 22:05:35 as **
  • Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
    Neurology, Vol. 54, No. 7. (11 April 2000), pp. 1482-1487.
    posted to d2 dopamine extra-striatal pd by ntvandehey on 2007-09-21 20:27:56 as **
  • Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study.
    J Neural Transm, Vol. 110, No. 6. (June 2003), pp. 591-601.
    by V Kaasinen, S Aalto, K NAgren, J Hietala, P Sonninen, JO Rinne
    posted to d2 dopamine extra-striatal flb library_express pd by ntvandehey on 2007-09-21 20:25:57 as *****
  • Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease.
    Neuroreport, Vol. 16, No. 17. (28 November 2005), pp. 1877-1881.
    posted to dbs pd ppn by ntvandehey on 2007-08-03 16:31:23 as ***
  • Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Brain, Vol. 130, No. Pt 6. (June 2007), pp. 1596-1607.
    posted to dbs pd ppn by ntvandehey on 2007-08-03 16:30:53 as ***
  • Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility
    J Cereb Blood Flow Metab, Vol. 27, No. 3. (28 June 2006), pp. 597-605.
    by Yilong Ma, Chengke Tang, Phoebe G Spetsieris, Vijay Dhawan, David Eidelberg
    posted to dbs fdg h2o pd pet by ntvandehey on 2007-08-03 16:26:24 as **
  • Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.
    Chin Med J (Engl), Vol. 117, No. 9. (September 2004), pp. 1304-1308.
    by YB Zhao, BM Sun, DY Li, QS Wang
    posted to dbs fdg pd stn by ntvandehey on 2007-08-03 16:52:05 as ** along with 1 person mbolding
  • FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease.
    Acta Neurochir Suppl, Vol. 99 (2006), pp. 51-54.
    by D Li, C Zuo, Y Guan, Y Zhao, J Shen, S Zan, B Sun
    posted to dbs fdg pd pet stn by ntvandehey on 2007-08-03 16:51:36 as ***
  • Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
    J Nucl Med, Vol. 43, No. 6. (June 2002), pp. 725-732.
    posted to dbs pd rcbf stn by ntvandehey on 2007-08-03 16:47:28 as **
  • Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease.
    Neuroreport, Vol. 16, No. 17. (28 November 2005), pp. 1883-1887.
    by P Plaha, SS Gill
    posted to dbs pd ppn by ntvandehey on 2007-08-03 16:44:47 as **
  • Deep brain stimulation: neuropsychological and neuropsychiatric issues.
    Movement disorders : official journal of the Movement Disorder Society, Vol. 21 Suppl 14 (June 2006)
    by V Voon, C Kubu, P Krack, JL Houeto, AI Tröster
    posted to pd patient dbs by nishiokov on 2008-07-03 12:33:11 as **
  • Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
    Journal of molecular neuroscience : MN, Vol. 24, No. 3. (2004), pp. 401-416.
    by S Mandel, G Maor, MB Youdim
    posted to pd iron by monimonicas on 2008-05-26 05:39:21 as **
  • Brain iron pathways and their relevance to Parkinson's disease.
    Journal of neurochemistry, Vol. 79, No. 2. (October 2001), pp. 225-236.
    by D Berg, M Gerlach, MB Youdim, KL Double, L Zecca, P Riederer, G Becker
    posted to pd iron by monimonicas on 2008-05-26 05:39:13 as **
  • Iron trafficking inside the brain
    Journal of Neurochemistry, Vol. 103, No. 5. (December 2007), pp. 1730-1740.
    posted to pd iron by monimonicas on 2008-05-26 05:39:05 as **
  • What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
    Journal of neural transmission. Supplementum, No. 65. (2003), pp. 73-88.
    by MB Youdim
    posted to pd iron by monimonicas on 2008-05-26 05:38:45 as **
  • Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Ageing research reviews, Vol. 3, No. 3. (July 2004), pp. 327-343.
    by D Kaur, J Andersen
    posted to pd iron by monimonicas on 2008-05-26 05:38:37 as **
  • Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Ann N Y Acad Sci, Vol. 1012 (March 2004), pp. 306-325.
    posted to pd iron by monimonicas on 2008-05-26 05:38:23 as ** along with 1 person and 1 group dep Glimcher_Lab
  • Brain iron homeostasis.
    Danish medical bulletin, Vol. 49, No. 4. (November 2002), pp. 279-301.
    by T Moos
    posted to pd iron by monimonicas on 2008-05-26 05:38:13 as **
  • Iron dysregulation and Parkinson's disease.
    Journal of Alzheimer's disease : JAD, Vol. 6, No. 6 Suppl. (December 2004)
    by JK Andersen
    posted to pd iron by monimonicas on 2008-05-26 05:37:47 as **
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/pd

    Result page: 1 2 3 4 5 6 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.